Seres Therapeutics Inc (MCRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2012 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 114,185 | 1,654 | 0 | N/A |
| TOTAL | $114,243 | $1,705 | $0 | $N/A |
| Non-Current Assets | ||||
| PPE Net | 1,264 | 352 | 0 | N/A |
| Other Non-Current Assets | 1,838 | 68 | 0 | 0 |
| TOTAL | $3,102 | $420 | $N/A | $N/A |
| Total Assets | $117,345 | $2,125 | $0 | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 2,166 | 393 | 0 | 0 |
| Accrued Expenses | 1,737 | 263 | 0 | N/A |
| TOTAL | $5,103 | $1,056 | $0 | $N/A |
| Non-Current Liabilities | ||||
| Long Term Debt | 1,304 | 438 | 0 | N/A |
| Other Non-Current Liabilities | 137,659 | 11,747 | 0 | 0 |
| TOTAL | $138,963 | $12,185 | $N/A | $N/A |
| Total Liabilities | $144,066 | $13,241 | $0 | $N/A |
| Shareholders' Equity | ||||
| Common Shares | 7 | 7 | 0 | N/A |
| Retained earnings | -27,832 | -11,123 | 0 | N/A |
| TOTAL | $-26,721 | $-11,116 | $0 | $N/A |
| Total Liabilities And Equity | $117,345 | $2,125 | $0 | $0 |